Skip to content

WEST PHARMACEUTICAL SERVICES INC

WST

CIK 0000105770

← back to feed
Revenue (TTM)
$3.11B
+6.3% YoY Q1 Apr 2026
Net Income (TTM)
$500.4M
+0.2% YoY Q1 Apr 2026
EPS Diluted (TTM)
$6.89
+1.5% YoY Q1 Apr 2026
Gross Margin
35.2%
Q1 Apr 2026
Operating Margin
19.4%
Q1 Apr 2026
Net Margin
16.1%
Q1 Apr 2026
Free Cash Flow (TTM)
$188.9M
Q1 Apr 2026
Cash
$521.4M
Q1 Apr 2026
Total Debt
$205M
Q1 Apr 2026
Shares Outstanding
70.65M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings